Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127052661 | 12705266 | 1 | I | 20160617 | 20160824 | 20160831 | 20160831 | EXP | US-AMGEN-USASL2016113841 | AMGEN | 78.00 | YR | E | M | Y | 0.00000 | 20160831 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127052661 | 12705266 | 1 | PS | PROCRIT | ERYTHROPOIETIN | 1 | Unknown | 40,000 UNITS, PRN | U | 103234 | SOLUTION FOR INJECTION | ||||||||
| 127052661 | 12705266 | 2 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | 300 MG, DAILY | 0 | 300 | MG | TABLET | QD | ||||||
| 127052661 | 12705266 | 3 | C | WARFARIN SODIUM. | WARFARIN SODIUM | 1 | Oral | UNK, TAKE AS DIRECTED | 0 | TABLET | |||||||||
| 127052661 | 12705266 | 4 | C | AMLODIPINE BESYLATE. | AMLODIPINE BESYLATE | 1 | Oral | 5 MG, DAILY | 0 | 5 | MG | TABLET | QD | ||||||
| 127052661 | 12705266 | 5 | C | CARVEDILOL. | CARVEDILOL | 1 | Oral | 6.25 MG, DAILY | 0 | 6.25 | MG | TABLET | QD | ||||||
| 127052661 | 12705266 | 6 | C | CITALOPRAM HYDROBROMIDE. | CITALOPRAM HYDROBROMIDE | 1 | Oral | 20 MG, DAILY | 0 | 20 | MG | TABLET | QD | ||||||
| 127052661 | 12705266 | 7 | C | FERROUS SULFATE. | FERROUS SULFATE | 1 | Oral | 325 MG, DAILY | 0 | 325 | MG | TABLET | QD | ||||||
| 127052661 | 12705266 | 8 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 40 MG, DAILY | 0 | 40 | MG | TABLET | QD | ||||||
| 127052661 | 12705266 | 9 | C | VITAMIN D | CHOLECALCIFEROL | 1 | Oral | 1,000 UNITS, DAILY | 0 | CAPSULE | QD | ||||||||
| 127052661 | 12705266 | 10 | C | COUMADIN | WARFARIN SODIUM | 1 | UNK | 0 | |||||||||||
| 127052661 | 12705266 | 11 | C | FOLIC ACID. | FOLIC ACID | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127052661 | 12705266 | 1 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127052661 | 12705266 | HO |
| 127052661 | 12705266 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127052661 | 12705266 | Back disorder | |
| 127052661 | 12705266 | Dyspnoea | |
| 127052661 | 12705266 | Ecchymosis | |
| 127052661 | 12705266 | Fatigue | |
| 127052661 | 12705266 | Haematoma | |
| 127052661 | 12705266 | Haemoglobin decreased | |
| 127052661 | 12705266 | Hypergammaglobulinaemia benign monoclonal | |
| 127052661 | 12705266 | Marrow hyperplasia | |
| 127052661 | 12705266 | Myelodysplastic syndrome | |
| 127052661 | 12705266 | Petechiae | |
| 127052661 | 12705266 | Platelet count abnormal | |
| 127052661 | 12705266 | Renal failure | |
| 127052661 | 12705266 | Scratch | |
| 127052661 | 12705266 | Skin irritation | |
| 127052661 | 12705266 | Staphylococcal infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |